Terms ending in 2042
Every in-force patent on Alector LLC's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,780,946 | Anti-Mertk Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 12,227,568 | ANTI-SIGLEC-7 Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 11,987,612 | SIGLEC-9 Ecd Fusion Molecules In force · High confidence | Alector LLC | In force | High confidence | |
| US 12,247,073 | ANTI-CD33 Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.